Matches in SemOpenAlex for { <https://semopenalex.org/work/W4289204872> ?p ?o ?g. }
- W4289204872 endingPage "1595" @default.
- W4289204872 startingPage "1595" @default.
- W4289204872 abstract "Parkinson’s disease (PD) is characterized by dopaminergic nigrostriatal neurons degeneration and Lewy body pathology, mainly composed of α-synuclein (αSyn) fibrillary aggregates. We recently described that the neuronal phosphoprotein Synapsin III (Syn III) participates in αSyn pathology in PD brains and is a permissive factor for αSyn aggregation. Moreover, we reported that the gene silencing of Syn III in a human αSyn transgenic (tg) mouse model of PD at a pathological stage, manifesting marked insoluble αSyn deposits and dopaminergic striatal synaptic dysfunction, could reduce αSyn aggregates, restore synaptic functions and motor activities and exert neuroprotective effects. Interestingly, we also described that the monoamine reuptake inhibitor methylphenidate (MPH) can recover the motor activity of human αSyn tg mice through a dopamine (DA) transporter-independent mechanism, which relies on the re-establishment of the functional interaction between Syn III and α-helical αSyn. These findings support that the pathological αSyn/Syn III interaction may constitute a therapeutic target for PD. Here, we studied MPH and some of its analogues as modulators of the pathological αSyn/Syn III interaction. We identified 4-methyl derivative I-threo as a lead candidate modulating αSyn/Syn III interaction and having the ability to reduce αSyn aggregation in vitro and to restore the motility of αSyn tg mice in vivo more efficiently than MPH. Our results support that MPH derivatives may represent a novel class of αSyn clearing agents for PD therapy." @default.
- W4289204872 created "2022-08-01" @default.
- W4289204872 creator A5010729201 @default.
- W4289204872 creator A5015134233 @default.
- W4289204872 creator A5024225975 @default.
- W4289204872 creator A5038229395 @default.
- W4289204872 creator A5050044740 @default.
- W4289204872 creator A5053944964 @default.
- W4289204872 creator A5068947190 @default.
- W4289204872 creator A5072785722 @default.
- W4289204872 creator A5072906788 @default.
- W4289204872 creator A5074286098 @default.
- W4289204872 creator A5078762830 @default.
- W4289204872 creator A5079745354 @default.
- W4289204872 creator A5087636583 @default.
- W4289204872 date "2022-07-30" @default.
- W4289204872 modified "2023-09-26" @default.
- W4289204872 title "Methylphenidate Analogues as a New Class of Potential Disease-Modifying Agents for Parkinson’s Disease: Evidence from Cell Models and Alpha-Synuclein Transgenic Mice" @default.
- W4289204872 cites W1984734436 @default.
- W4289204872 cites W1989730458 @default.
- W4289204872 cites W1995800834 @default.
- W4289204872 cites W1998876462 @default.
- W4289204872 cites W2009654376 @default.
- W4289204872 cites W2026412511 @default.
- W4289204872 cites W2032730800 @default.
- W4289204872 cites W2033827101 @default.
- W4289204872 cites W2036967836 @default.
- W4289204872 cites W2038622931 @default.
- W4289204872 cites W2039484126 @default.
- W4289204872 cites W2044468559 @default.
- W4289204872 cites W2053177584 @default.
- W4289204872 cites W2054394841 @default.
- W4289204872 cites W2066892437 @default.
- W4289204872 cites W2077502289 @default.
- W4289204872 cites W2082313873 @default.
- W4289204872 cites W2091676509 @default.
- W4289204872 cites W2116639272 @default.
- W4289204872 cites W2124405216 @default.
- W4289204872 cites W2128658902 @default.
- W4289204872 cites W2129279466 @default.
- W4289204872 cites W2132629607 @default.
- W4289204872 cites W2134967712 @default.
- W4289204872 cites W2137606977 @default.
- W4289204872 cites W2138572297 @default.
- W4289204872 cites W2145294211 @default.
- W4289204872 cites W2153884058 @default.
- W4289204872 cites W2162380002 @default.
- W4289204872 cites W2170652518 @default.
- W4289204872 cites W2177150432 @default.
- W4289204872 cites W2178916357 @default.
- W4289204872 cites W2259666511 @default.
- W4289204872 cites W2270885507 @default.
- W4289204872 cites W2319500824 @default.
- W4289204872 cites W2356842414 @default.
- W4289204872 cites W2396930286 @default.
- W4289204872 cites W2519425563 @default.
- W4289204872 cites W2562674913 @default.
- W4289204872 cites W2591620984 @default.
- W4289204872 cites W2593436234 @default.
- W4289204872 cites W2615136515 @default.
- W4289204872 cites W2617750324 @default.
- W4289204872 cites W2623172571 @default.
- W4289204872 cites W2746927775 @default.
- W4289204872 cites W2760894280 @default.
- W4289204872 cites W2768047886 @default.
- W4289204872 cites W2777102373 @default.
- W4289204872 cites W2783654252 @default.
- W4289204872 cites W2791829813 @default.
- W4289204872 cites W2806953769 @default.
- W4289204872 cites W2883573946 @default.
- W4289204872 cites W2908157132 @default.
- W4289204872 cites W2929595044 @default.
- W4289204872 cites W2962729078 @default.
- W4289204872 cites W3008485740 @default.
- W4289204872 cites W3015438624 @default.
- W4289204872 cites W3032298637 @default.
- W4289204872 cites W3086856825 @default.
- W4289204872 cites W3170988898 @default.
- W4289204872 cites W3202585445 @default.
- W4289204872 cites W4205773833 @default.
- W4289204872 doi "https://doi.org/10.3390/pharmaceutics14081595" @default.
- W4289204872 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/36015221" @default.
- W4289204872 hasPublicationYear "2022" @default.
- W4289204872 type Work @default.
- W4289204872 citedByCount "3" @default.
- W4289204872 countsByYear W42892048722023 @default.
- W4289204872 crossrefType "journal-article" @default.
- W4289204872 hasAuthorship W4289204872A5010729201 @default.
- W4289204872 hasAuthorship W4289204872A5015134233 @default.
- W4289204872 hasAuthorship W4289204872A5024225975 @default.
- W4289204872 hasAuthorship W4289204872A5038229395 @default.
- W4289204872 hasAuthorship W4289204872A5050044740 @default.
- W4289204872 hasAuthorship W4289204872A5053944964 @default.
- W4289204872 hasAuthorship W4289204872A5068947190 @default.
- W4289204872 hasAuthorship W4289204872A5072785722 @default.
- W4289204872 hasAuthorship W4289204872A5072906788 @default.
- W4289204872 hasAuthorship W4289204872A5074286098 @default.
- W4289204872 hasAuthorship W4289204872A5078762830 @default.